Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Tyrosine Kinase Inhibitors [MoA]

Known as: Tyrosine Kinase Inhibitors 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Activating mutations of the epidermal growth factor receptor gene (EGFR) are a driving force for some lung adenocarcinomas… Expand
  • table 1
  • figure 1
Is this relevant?
Review
2019
Review
2019
Angiogenesis has always been the topic of major scientific interest in the field of malignant tumors. Nowadays, targeting… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2019
Review
2019
BACKGROUND Nivolumab-ipilimumab demonstrated a survival benefit over sunitinib in first-line setting for metastatic renal cell… Expand
Is this relevant?
Review
2018
Review
2018
Renal cell carcinoma (RCC) is the most common form of kidney cancer. It is categorized into various subtypes, with clear cell RCC… Expand
  • figure 1
Is this relevant?
Review
2017
Review
2017
Medullary thyroid carcinoma (MTC) represents 3-5% of thyroid cancers. 75% is sporadic and 25% is the dominant component of the… Expand
  • table 1
Is this relevant?
Review
2016
Review
2016
Fibroblast growth factors (FGFs) regulate a plethora of biological functions, in both the embryonic and adult stages of… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Multiple mechanisms of crizotinib resistance were identified in lung cancer patients including new secondary ALK mutations and… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE The EML4-ALK fusion oncogene represents a novel molecular target in a small subset of non-small-cell lung cancers (NSCLC… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Oncogenic tyrosine kinases have proved to be promising targets for the development of highly effective anticancer drugs. However… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?